Effects of Perioperative Oral Management in Patients with Cancer
Perioperative oral management (POM) is used to prevent pneumonia in patients with cancer. However, the factors that expose hospitalized patients to increased risk of developing pneumonia remain unclear. For example, no study to date has compared the incidence of pneumonia in hospitalized patients by...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-11-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/11/21/6576 |
| _version_ | 1797467743585304576 |
|---|---|
| author | Yasuhiro Kurasawa Akihiko Iida Kaya Narimatsu Hideki Sekiya Yutaka Maruoka Yukihiro Michiwaki |
| author_facet | Yasuhiro Kurasawa Akihiko Iida Kaya Narimatsu Hideki Sekiya Yutaka Maruoka Yukihiro Michiwaki |
| author_sort | Yasuhiro Kurasawa |
| collection | DOAJ |
| description | Perioperative oral management (POM) is used to prevent pneumonia in patients with cancer. However, the factors that expose hospitalized patients to increased risk of developing pneumonia remain unclear. For example, no study to date has compared the incidence of pneumonia in hospitalized patients by cancer primary lesion, or POM implementation, or not. We determined which patients were most likely to benefit from POM and examined the effects of POM on pneumonia prevention and mortality. In a total of 9441 patients with cancer who underwent surgery during hospitalization, there were 8208 patients in the No POM group, and 1233 in the POM group. We examined between-group differences in the incidence of pneumonia and associated outcomes during hospitalization. There was no significant between-group difference in the incidence of pneumonitis, however, patients with lung, or head and neck cancers, demonstrated a lower incidence of postoperative pneumonia. Among patients with lung and pancreatic cancers, mortality was significantly lower in the POM group. POM appears effective at reducing the risk of postoperative pneumonia in patients with certain cancers. Further, mortality was significantly lower in patients with lung and pancreatic cancers who received POM; hence, POM may be an effective adjuvant therapy for patients with cancer. |
| first_indexed | 2024-03-09T18:58:04Z |
| format | Article |
| id | doaj.art-d273fda8f150413da17f48bfd480e050 |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-09T18:58:04Z |
| publishDate | 2022-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-d273fda8f150413da17f48bfd480e0502023-11-24T05:19:56ZengMDPI AGJournal of Clinical Medicine2077-03832022-11-011121657610.3390/jcm11216576Effects of Perioperative Oral Management in Patients with CancerYasuhiro Kurasawa0Akihiko Iida1Kaya Narimatsu2Hideki Sekiya3Yutaka Maruoka4Yukihiro Michiwaki5Maxillofacial Surgery, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8520, JapanDepartment of Dentistry and Oral Surgery, Nagaoka Red Cross Hospital, Niigata 940-2085, JapanDepartment of Dentistry and Oral Surgery, Nagaoka Red Cross Hospital, Niigata 940-2085, JapanDepartment of Oral Surgery, School of Medicine, Toho University, Tokyo 143-8541, JapanOral and Maxillofacial Surgery, Center Hospital of the National Center for Global Health and Medicine, Tokyo 162-8655, JapanDepartment of Oral Surgery, School of Medicine, Toho University, Tokyo 143-8541, JapanPerioperative oral management (POM) is used to prevent pneumonia in patients with cancer. However, the factors that expose hospitalized patients to increased risk of developing pneumonia remain unclear. For example, no study to date has compared the incidence of pneumonia in hospitalized patients by cancer primary lesion, or POM implementation, or not. We determined which patients were most likely to benefit from POM and examined the effects of POM on pneumonia prevention and mortality. In a total of 9441 patients with cancer who underwent surgery during hospitalization, there were 8208 patients in the No POM group, and 1233 in the POM group. We examined between-group differences in the incidence of pneumonia and associated outcomes during hospitalization. There was no significant between-group difference in the incidence of pneumonitis, however, patients with lung, or head and neck cancers, demonstrated a lower incidence of postoperative pneumonia. Among patients with lung and pancreatic cancers, mortality was significantly lower in the POM group. POM appears effective at reducing the risk of postoperative pneumonia in patients with certain cancers. Further, mortality was significantly lower in patients with lung and pancreatic cancers who received POM; hence, POM may be an effective adjuvant therapy for patients with cancer.https://www.mdpi.com/2077-0383/11/21/6576perioperative oral managementincidence of pneumoniamortality |
| spellingShingle | Yasuhiro Kurasawa Akihiko Iida Kaya Narimatsu Hideki Sekiya Yutaka Maruoka Yukihiro Michiwaki Effects of Perioperative Oral Management in Patients with Cancer Journal of Clinical Medicine perioperative oral management incidence of pneumonia mortality |
| title | Effects of Perioperative Oral Management in Patients with Cancer |
| title_full | Effects of Perioperative Oral Management in Patients with Cancer |
| title_fullStr | Effects of Perioperative Oral Management in Patients with Cancer |
| title_full_unstemmed | Effects of Perioperative Oral Management in Patients with Cancer |
| title_short | Effects of Perioperative Oral Management in Patients with Cancer |
| title_sort | effects of perioperative oral management in patients with cancer |
| topic | perioperative oral management incidence of pneumonia mortality |
| url | https://www.mdpi.com/2077-0383/11/21/6576 |
| work_keys_str_mv | AT yasuhirokurasawa effectsofperioperativeoralmanagementinpatientswithcancer AT akihikoiida effectsofperioperativeoralmanagementinpatientswithcancer AT kayanarimatsu effectsofperioperativeoralmanagementinpatientswithcancer AT hidekisekiya effectsofperioperativeoralmanagementinpatientswithcancer AT yutakamaruoka effectsofperioperativeoralmanagementinpatientswithcancer AT yukihiromichiwaki effectsofperioperativeoralmanagementinpatientswithcancer |